These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35394110)

  • 1. People with HIV have a higher risk of COVID-19 diagnosis but similar outcomes to the general population.
    Tang ME; Gaufin T; Anson R; Zhu W; Mathews WC; Cachay ER
    HIV Med; 2022 Nov; 23(10):1069-1077. PubMed ID: 35394110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 hospitalization outcomes in adults by HIV status; a nation-wide register-based study.
    Möller IK; Gisslén M; Wagner P; Sparén P; Carlander C
    HIV Med; 2023 Oct; 24(10):1045-1055. PubMed ID: 37286199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Testing Among People with HIV: A Population Level Analysis Based on Statewide Data in South Carolina.
    Shi F; Zhang J; Yang X; Gao H; Chen S; Weissman S; Olatosi B; Li X
    AIDS Behav; 2024 Oct; 28(Suppl 1):22-32. PubMed ID: 38109020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between post-acute sequelae of SARS-CoV-2, COVID-19 vaccination and HIV infection: a United States cohort study.
    Yendewa GA; Perez JA; Patil N; McComsey GA
    Front Immunol; 2024; 15():1297195. PubMed ID: 38318191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.
    Nomah DK; Reyes-Urueña J; Díaz Y; Moreno S; Aceiton J; Bruguera A; Vivanco-Hidalgo RM; Llibre JM; Domingo P; Falcó V; Imaz A; Cortés C; Force L; Letang E; Vilaró I; Casabona J; Miro JM;
    Lancet HIV; 2021 Nov; 8(11):e701-e710. PubMed ID: 34655549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.
    Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon KS; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg MJ; Skarbinski J; Leyden WA; Williams CF; Althoff KN;
    JAMA Netw Open; 2022 Jun; 5(6):e2215934. PubMed ID: 35671054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Severity in People With HIV Compared With Those Without HIV.
    Nguyen VT; Nagavedu K; Morrison M; Chen T; Randall LM; Landazabal C; John B; Klompas M; Cocoros NM
    J Acquir Immune Defic Syndr; 2024 Apr; 95(5):479-485. PubMed ID: 38301641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 percent positivity and risk factors among people with HIV at an urban academic medical center.
    Friedman EE; Devlin SA; McNulty MC; Ridgway JP
    PLoS One; 2021; 16(7):e0254994. PubMed ID: 34288954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes following severe acute respiratory syndrome coronavirus 2 infection among individuals with and without HIV in Denmark.
    Rasmussen LD; Cowan S; Gerstoft J; Kronborg G; Johansen IS; Larsen CS; Weise L; Dalager-Pedersen M; Leth S; Nielsen LN; Lunding S; Omland LH; Obel N
    AIDS; 2023 Feb; 37(2):311-321. PubMed ID: 36129108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major cardiovascular events after COVID-19 in people with HIV.
    Martín-Iguacel R; Moreno-Fornés S; Bruguera A; Aceitón J; Nomah DK; González-Cordón A; Domingo P; Curran A; Imaz A; Juanola DD; Peraire J; Borjabad B; Fernandez LA; Johansen IS; Miró JM; Casabona J; Llibre JM;
    Clin Microbiol Infect; 2024 May; 30(5):674-681. PubMed ID: 38342439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression Risk in People with HIV and COVID-19: Predictive Performance of Current Risk Scores.
    Vizcarra P; Cabello A; Moreno A; Vivancos MJ; López-Botet J; Zamarro B; Górgolas M; Casado JL
    AIDS Res Hum Retroviruses; 2021 Aug; 37(8):613-619. PubMed ID: 33913732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between comorbidities and coronavirus disease 2019 hospitalization among people with HIV differs by age.
    Moran CA; Oliver NT; Szabo B; Collins LF; Nguyen MLT; Shah NS; Moanna A; Colasanti JA; Cantos VD; Armstrong WS; Sheth AN; Ofotokun I; Kelley CF; Marconi VC; Lahiri CD
    AIDS; 2023 Jan; 37(1):71-81. PubMed ID: 36111530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Outcomes Among People With HIV and COVID-19 in New York City.
    Braunstein SL; Wahnich A; Lazar R
    J Infect Dis; 2023 Nov; 228(11):1571-1582. PubMed ID: 37534822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Testing and Positivity Among Persons With and Without HIV in 6 US Cohorts.
    Park LS; McGinnis KA; Gordon KS; Justice AC; Leyden W; Silverberg MJ; Skarbinski J; Jefferson C; Horberg M; Certa J; Napravnik S; Edwards JK; Westreich D; Bastarache L; Gangireddy S; Benning L; D'Souza G; Williams C; Althoff KN;
    J Acquir Immune Defic Syndr; 2022 Jul; 90(3):249-255. PubMed ID: 35195574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US.
    Lang R; Humes E; Coburn SB; Horberg MA; Fathi LF; Watson E; Jefferson CR; Park LS; Gordon KS; Akgün KM; Justice AC; Napravnik S; Edwards JK; Browne LE; Agil DM; Silverberg MJ; Skarbinski J; Leyden WA; Stewart C; Hogan BC; Gebo KA; Marconi VC; Williams CF; Althoff KN;
    JAMA Netw Open; 2022 Oct; 5(10):e2236397. PubMed ID: 36227594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief Report: COVID-19 Testing, Characteristics, and Outcomes Among People Living With HIV in an Integrated Health System.
    Chang JJ; Bruxvoort K; Chen LH; Akhavan B; Rodriguez J; Hechter RC
    J Acquir Immune Defic Syndr; 2021 Sep; 88(1):1-5. PubMed ID: 34397741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study.
    Hanna JJ; Geresu LB; Diaz MI; Ho M; Casazza JA; Pickering MA; Lanier HD; Radunsky AP; Cooper LN; Saleh SN; Bedimo RJ; Most ZM; Perl TM; Lehmann CU; Turer RW; Chow JY; Medford RJ
    Open Forum Infect Dis; 2023 Aug; 10(8):ofad400. PubMed ID: 37577110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated With Severity of COVID-19 Disease in a Multicenter Cohort of People With HIV in the United States, March-December 2020.
    Shapiro AE; Bender Ignacio RA; Whitney BM; Delaney JA; Nance RM; Bamford L; Wooten D; Keruly JC; Burkholder G; Napravnik S; Mayer KH; Webel AR; Kim HN; Van Rompaey SE; Christopoulos K; Jacobson J; Karris M; Smith D; Johnson MO; Willig A; Eron JJ; Hunt P; Moore RD; Saag MS; Mathews WC; Crane HM; Cachay ER; Kitahata MM;
    J Acquir Immune Defic Syndr; 2022 Aug; 90(4):369-376. PubMed ID: 35364600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus Disease 2019 (COVID-19) Infection Among People With Human Immunodeficiency Virus in New York City: A Population-Level Analysis of Linked Surveillance Data.
    Braunstein SL; Lazar R; Wahnich A; Daskalakis DC; Blackstock OJ
    Clin Infect Dis; 2021 Jun; 72(12):e1021-e1029. PubMed ID: 33252620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV.
    Overton ET; Weir IR; Zanni MV; Fischinger S; MacArthur RD; Aberg JA; Fitch KV; Frank M; Albrecht H; Goodenough E; Rhame FS; Fichtenbaum CJ; Bloomfield GS; Malvestutto C; Supparatpinyo K; McCallum S; Douglas PS; Alter G; Ribaudo H; Grinspoon SK
    J Acquir Immune Defic Syndr; 2022 Aug; 90(4):377-381. PubMed ID: 35413022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.